The Faroese Health Authority (Fólkaheilsustýrið) performs FarGen 2 in collaboration with the American company, Variant Bio, and Ass. Prof. Fernando Racimo from the University of Copenhagen. The overall goal is to investigate the population history of the Faroese and to perform perform association analysis between genetic variants and disease. Read more about the partners here:
FarGen 2 also collaborates with specialists at the National Hospital of the Faroe Islands (Landssjúkrahúsið) within the focus areas of FarGen 2: diabetes, IBD, spondylartropathy and blood pressure.